Skip to main content
Log in

Follow-up of cases with false-negative pathologic sentinel nodes in breast cancer

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

The clinical practice of sentinel lymph node biopsy for breast cancer patients started in 1999 in our hospital, to obviate unnecessary axillary lymph node dissection. The present study examines the pathological false-negative cases on intraoperative sentinel lymph node investigations and evaluates their outcomes.

Methods

The subjects consisted of 183 cases with clinically node-negative breast cancer who had undergone sentinel node biopsy. When the sentinel node was noted to contain malignant cells intraoperatively, a complete axillary lymph node dissection was performed subsequently. The patients with tumor free sentinel nodes underwent no further axillary surgery. The pathological false-negative cases in this series were defined as patients with lymph node involvement which was revealed postoperatively, despite negative intraoperative sentinel node examinations. After these surgeries and/or adjuvant therapies, interval clinical evaluations were performed for all patients.

Result

Intraoperative diagnosis of the sentinel node was 96.2% accurate compared with the results of permanent sections. There were six pathological false-negative cases, a false-negative rate of 4.1%, all of which had only micrometastasis. Five cases received systemic adjuvant therapy and have been disease-free, however, one patient who refused further therapy developed infraclavicular lymph node metastasis two years after surgery.

Conclusions

In the management of the patients with postoperatively revealed sentinel node micrometastasis, systemic adjuvant therapies might reduce local relapse without secondary lymph node dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

HE:

Hematoxylin and Eosin

IHC:

Immunohistochemistry

CMF:

Cyclophosphamide-Methotrexate-Fluorouracil therapy

TAM:

Tamoxifen

DCIS:

Ductal carcinomain situ

References

  1. Cabanas RM: An approach for the treatment of penile carcinoma.Cancer 39:456–466, 1977.

    Article  PubMed  CAS  Google Scholar 

  2. The World Health Organization: Histological typing of breast tumors.Neoplasma 30:113–123, 1983.

    Google Scholar 

  3. Liberman L: Pathologic analysis of sentinel lymph nodes in breast carcinoma.Cancer 88:971–977, 2000.

    Article  PubMed  CAS  Google Scholar 

  4. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2:335–339, 1993.

    Article  PubMed  CAS  Google Scholar 

  5. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 220:391–401, 1994.

    Article  PubMed  CAS  Google Scholar 

  6. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 276:1818–1822, 1996.

    Article  PubMed  CAS  Google Scholar 

  7. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S, Koyama H: Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery.Br J Surg 87:597–601, 2000.

    Article  PubMed  CAS  Google Scholar 

  8. Kane JM, Edge SB, Winston JS, Watroba N, Hurd TC: Intraoperative pathologic evaluation of a breast cancer entinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection.Ann Surg Oncol 8:361–367, 2001.

    Article  PubMed  Google Scholar 

  9. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer.Ann Surg Oncol 5:689–694, 1998.

    Article  PubMed  CAS  Google Scholar 

  10. Van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, Meijer S: Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer.Histopathology 35:14–18, 1999.

    Article  PubMed  Google Scholar 

  11. Noguchi M, Tsugawa K, Kawahara F, Bando E, Miwa K, Minato H, Nonomura A: Dye-Guided Sentinel Lymphadenectomy in Clinically Node-Negative and Node-Positive Breast Cancer Patients.Breast Cancer 5:381–387, 1998.

    Article  PubMed  Google Scholar 

  12. Cserni G: The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients.Am Surg 67:86–91, 2001.

    PubMed  CAS  Google Scholar 

  13. Ratanawichitrasin A, Biscotti CV, Levy L, Crowe JP: Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer.Br J Surg 86:1346–1348, 1999.

    Article  PubMed  CAS  Google Scholar 

  14. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O’Connell M: Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study.Cancer 88:1099–1107, 2000.

    Article  PubMed  CAS  Google Scholar 

  15. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph-node in breast cancer.Lancet 349:1668–1669, 1997.

    Article  PubMed  CAS  Google Scholar 

  16. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer.J Clin Oncol 15:2345–2350, 1997.

    PubMed  CAS  Google Scholar 

  17. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurri-da S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet 349:1864–1867, 1997.

    Article  PubMed  CAS  Google Scholar 

  18. Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting.Cancer J Sci Am 3:336–340, 1997.

    PubMed  CAS  Google Scholar 

  19. Offodile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR, Economou JS, Nguyen M: Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran.Cancer 82:1704–1708, 1998.

    Article  PubMed  CAS  Google Scholar 

  20. Nano MT, Kollias J, Farshid G, Gill PG, Bochner M: Clinical impact of false-negative sentinel node biopsy in primary breast cancer.Br J Surg 89:1430–1434, 2002.

    Article  PubMed  CAS  Google Scholar 

  21. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer-a multicenter validation study.N Engl J Med 339:941–646, 1998.

    Article  PubMed  CAS  Google Scholar 

  22. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 227:645–653, 1998.

    Article  PubMed  CAS  Google Scholar 

  23. Hill AD, Tran KN, Akhurst T, Yeung H, Yeh SD, Rosen PP, Borgen PI, Cody HS 3rd: Lessons learned from 500 cases of lymphatic mapping for breast cancer.Ann Surg 229:528–535, 1999.

    Article  PubMed  CAS  Google Scholar 

  24. Nieweg OE, Rutgers EJ, Jansen L, Valdes Olmos RA, Peterse JL, Hoefnagel KA, Kroon BB: Is lymphatic mapping in breast cancer adequate and safe?World J Surg 25:780–788, 2001.

    Article  PubMed  CAS  Google Scholar 

  25. Jakub JW, Diaz NM, Ebert MD, Cantor A, Reintgen DS, Dupont EL, Shons AR, Cox CE: Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes.Am J Surg 184:302–306, 2002.

    Article  PubMed  Google Scholar 

  26. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, Giuliano AE: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node.Cancer 89:574–581, 2000.

    Article  PubMed  CAS  Google Scholar 

  27. Rahusen FD, Torrenga H, van Diest PJ, Pijpers R, van derWallE, Licht J, Meijer S: Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer.Arch Surg 136:1059–1063, 2001.

    Article  PubMed  CAS  Google Scholar 

  28. Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blarney RW, Haybittle JL: Confirmation of a prognostic index in primary breast cancer.Br J Cancer 56:489–492, 1987.

    PubMed  CAS  Google Scholar 

  29. Forrest AP, Everington D, McDonald CC, Steele RJ, Chetty U, Stewart HJ: The Edinburgh randomized trial of axillary sampling or clearance after mastectomy.Br J Surg 82:1504–1508, 1995.

    Article  PubMed  CAS  Google Scholar 

  30. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Mar-golese R, Foster R: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.N Engl J Med 312:674–681, 1985.

    PubMed  CAS  Google Scholar 

  31. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?Ann Surg 229:536–541, 1999.

    Article  PubMed  CAS  Google Scholar 

  32. Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, O’Connell TX: Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.Arch Surg 138:52–56, 2003.

    Article  PubMed  Google Scholar 

  33. Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE: Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohisto-chemically detectable nonsentinel node metastasis.Ann Surg Oncol 6:756–761, 1999.

    Article  PubMed  CAS  Google Scholar 

  34. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?Clin Oncol 17:1720–1726 1999.

    CAS  Google Scholar 

  35. Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, Orel SG, Berlin J, Helsabeck C, Fraker DL, Reynolds C: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma.Cancer 85:1098–1103,1999.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Nagashima, T., Yagata, H., Nikaido, T. et al. Follow-up of cases with false-negative pathologic sentinel nodes in breast cancer. Breast Cancer 11, 175–179 (2004). https://doi.org/10.1007/BF02968298

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02968298

Key words

Navigation